2024-04-01 2025-03-31 false Capium Accounts Production 1.1 08884816 2024-04-01 2025-03-31 08884816 bus:AbridgedAccounts 2024-04-01 2025-03-31 08884816 bus:FRS102 2024-04-01 2025-03-31 08884816 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 08884816 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 08884816 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 08884816 2024-04-01 2025-03-31 08884816 2025-03-31 08884816 bus:RegisteredOffice 2024-04-01 2025-03-31 08884816 core:WithinOneYear 2025-03-31 08884816 core:AfterOneYear 2025-03-31 08884816 1 2024-04-01 2025-03-31 08884816 bus:Director1 2024-04-01 2025-03-31 08884816 bus:Director1 2025-03-31 08884816 bus:Director1 2023-04-01 2024-03-31 08884816 2023-04-01 08884816 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 08884816 2023-04-01 2024-03-31 08884816 2024-03-31 08884816 core:WithinOneYear 2024-03-31 08884816 core:AfterOneYear 2024-03-31 08884816 bus:EntityAccountantsOrAuditors 2023-04-01 2024-03-31 08884816 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 08884816 bus:OrdinaryShareClass1 2025-03-31 08884816 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 08884816 bus:OrdinaryShareClass1 2024-03-31 08884816 core:PlantMachinery 2024-04-01 2025-03-31 08884816 core:PlantMachinery 2025-03-31 08884816 core:PlantMachinery 2024-03-31 08884816 core:FurnitureFittings 2024-04-01 2025-03-31 08884816 core:FurnitureFittings 2025-03-31 08884816 core:FurnitureFittings 2024-03-31 08884816 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-03-31 08884816 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 08884816 core:NetGoodwill 2024-04-01 2025-03-31 08884816 core:NetGoodwill 2025-03-31 08884816 core:NetGoodwill 2024-03-31 08884816 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 08884816 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 08884816 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 08884816 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 08884816 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 08884816 core:Non-currentFinancialInstruments 2025-03-31 08884816 core:Non-currentFinancialInstruments 2024-03-31 08884816 core:ShareCapital 2025-03-31 08884816 core:ShareCapital 2024-03-31 08884816 core:RetainedEarningsAccumulatedLosses 2025-03-31 08884816 core:RetainedEarningsAccumulatedLosses 2024-03-31 08884816 dpl:Item1 2024-04-01 08884816 dpl:Item1 2025-03-31 08884816 dpl:Item1 2023-04-01 08884816 dpl:Item1 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 08884816
England and Wales

 

 

 


Abridged Accounts


for the year ended 31 March 2025

for

CLINICAL LOCUMS LIMITED

 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Intangible fixed assets 3 22,500   
Tangible fixed assets 4 85,901   
108,401   
Current assets      
Debtors: amounts falling due within one year 1,051    103,176 
Cash at bank and in hand 44,068    55,203 
45,119    158,379 
Creditors: amount falling due within one year (31,137)   (50,825)
Net current assets 13,982    107,554 
 
Total assets less current liabilities 122,383    107,554 
Net assets 122,383    107,554 
 

Capital and reserves
     
Called up share capital 5 100    100 
Profit and loss account 122,283    107,454 
Shareholders' funds 122,383    107,554 
 


For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The director of the company has elected not to include the Income Statement within the financial statements.
The financial statements were approved by the director on 24 December 2025 and were signed by:


-------------------------------
Dr. S T Faisal
Director
1
General Information
Clinical Locums Limited is a private company limited by shares and is incorporated in England and Wales. The address of the registered office is C/O Bluewater, Quadrant Court, 49 Calthorpe Road, Birmingham, B15 1TH. The nature of the company's operations and its principal activity was the provision of medical locum services.
1.

Accounting policies

Significant accounting policies
The company's financial statements have been prepared in compliance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the United Kingdom and the Republic of Ireland' and the Companies Act 2006.

The financial statements have been prepared under the historical cost convention and on a going concern basis. The financial statements comprise the unaudited financial statements of the company up to 31 March each year, and are stated in pound sterling, the company's functional and presentational currency.

The principal accounting policies applied in the preparation of these financial statements are set out below, these policies have been applied consistently to all the years presented, unless otherwise stated.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of trade discounts.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period.
Intangible assets
Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
Goodwill
Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of 10 years.
Tangible fixed assets
Tangible fixed assets, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery 25% Reducing Balance
Fixtures and Fittings 25% Reducing Balance
2.

Employees and Directors


Average number of employees during the year was 1 (2024 : 1).
3.

Intangible fixed assets

Cost Goodwill   Total
  £   £
At 01 April 2024  
Additions 25,000    25,000 
Disposals  
At 31 March 2025 25,000    25,000 
Amortisation
At 01 April 2024  
Charge for year 2,500    2,500 
On disposals  
At 31 March 2025 2,500    2,500 
Net book values
At 31 March 2025 22,500    22,500 
At 31 March 2024  


4.

Tangible fixed assets

Cost or valuation Plant and Machinery   Fixtures and Fittings   Total
  £   £   £
At 01 April 2024    
Additions 112,675    1,860    114,535 
Disposals    
At 31 March 2025 112,675    1,860    114,535 
Depreciation
At 01 April 2024    
Charge for year 28,169    465    28,634 
On disposals    
At 31 March 2025 28,169    465    28,634 
Net book values
Closing balance as at 31 March 2025 84,506    1,395    85,901 
Opening balance as at 01 April 2024    


5.

Share Capital

Allotted, called up and fully paid
2025
£
  2024
£
100 Ordinary shares of £1.00 each 100    100 
100    100 

2